Headlines

When the FDA found out about Kim Kardashian West's Instagram endorsement for Diclegis that stated, among other things, that “it’s been studied and there was no increased risk to the baby,” they quickly sent a warning letter to drug manufacturer Duchesnay, Inc.

If not for the actions of so many companies and asbestos-related industries, the issue of asbestos exposure, let alone an aggressive mesothelioma diagnosis, likely would never have been a thought for this family. However, there are researches, scientists, doctors and even patients who are working every day to bring…

From electing to attend summer camps to planning beach days and boat outings, summer activities can provide some welcome relief from the everyday routine, but they can also come with their fair share of safety concerns.

Blame that otherwise should have been shouldered by GM for not admitting and recalling this defect early on—or at the very least, informing the public of the defect—was instead refocused on an already overburdened and understaffed regulatory agency.

Today, BP disclosed to its investors that it recommends a $18.7 billion settlement to resolve the claims by the United States, the five Gulf Coast states, and local governments that filed suits against the oil company as a result of the 2010 Deepwater Horizon tragedy. Could BP finally be realizing that 2015 may be the…

Despite the anticipatory lull in case filings just prior to the 2014 Supreme Court decision on Halliburton Co. v. Erica P. John Fund, securities fraud class action litigation continues to play an active and growing role in protecting the integrity of the capital markets. This trend is likely to continue.

By now you may have already seen a press release by Garlock Sealing Technologies LLC and The Anchor Packing Company about a “settlement” of their bankruptcy involving asbestos claims, or TV advertisements about their plan of reorganization for resolving the bankruptcy.

With such immediate and resounding consequences, you’d think that medical devices would be scrutinized more than just about any manufactured product; subjected to test after test before being released for use in and on the public. But that’s just not the case.

In light of all the recent recalls, including those for Takata airbags and GM ignition switches, there are a number of good reasons to take cars that are less than a decade old to the dealer once a year, even if it is just for a simple oil change.

If BP can appeal some payments made through its Economic and Property Damages Settlement Agreement, then it only makes sense that claimants who are denied recovery would also have the right to appeal their decision.